Global Business Travel (GBTG) 10-Q 21 Jun 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	Jun. 21, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2021
Entity File Number	001-39576
Entity Central Index Key	0001820872
Entity Registrant Name	APOLLO STRATEGIC GROWTH CAPITAL
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-0598290
Entity Address, Address Line One	9 West 57th Street, 43rd Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10019
City Area Code	212
Local Phone Number	515-3200
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.00005 par value, and one-third of one warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.00005 par value, and one-third of one warrant
Trading Symbol	APSG.U
Security Exchange Name	NYSE
Class A Ordinary Shares
Document Information [Line Items]
Title of 12(b) Security	Class A ordinary share
Trading Symbol	APSG
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		81,681,000
Warrants included as part of the units
Document Information [Line Items]
Title of 12(b) Security	Warrants included as part of the units
Trading Symbol	APSG WS
Security Exchange Name	NYSE
Class B Ordinary Shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		20,420,250

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash	$ 331,541	$ 257,872
Prepaid expenses	975,081	1,125,255
Total current assets	1,306,622	1,383,127
Investments held in Trust Account	817,127,050	816,985,533
Total Assets	818,433,672	818,368,660
Current liabilities:
Accounts payable and accrued expenses	4,519,383	383,164
Advances from related party	4,222	373,517
Note payable - Sponsor	2,300,000	1,500,000
Total current liabilities	6,823,605	2,256,681
Derivative warrant liabilities	49,857,252	74,642,310
Deferred underwriting compensation	28,588,350	28,588,350
Total Liabilities	85,269,207	105,487,341
Class A ordinary shares subject to possible redemption (72,816,446 and 70,788,131 shares at approximately $10.00 per share as of March 31, 2021 and December 31, 2020, respectively)	728,164,460	707,881,310
Shareholders' equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	4,387,203	24,670,251
Retained earnings (accumulated deficit)	611,338	(19,671,808)
Total shareholders' equity	5,000,005	5,000,009
Total liabilities and shareholders' equity	818,433,672	818,368,660
Class A Ordinary Shares
Shareholders' equity:
Ordinary shares	443	545
Total shareholders' equity	443	545
Class A Ordinary Shares Subject to Redemption
Current liabilities:
Class A ordinary shares subject to possible redemption (72,816,446 and 70,788,131 shares at approximately $10.00 per share as of March 31, 2021 and December 31, 2020, respectively)	728,164,460	707,881,310
Class B Ordinary Shares
Shareholders' equity:
Ordinary shares	1,021	1,021
Total shareholders' equity	$ 1,021	$ 1,021

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Ordinary Shares
Common shares, par value, (per share)	$ 0.00005	$ 0.00005
Common shares, shares authorized	300,000,000	300,000,000
Common shares, shares issued	8,864,554	10,892,869
Common shares, shares outstanding	8,864,554	10,892,869
Temporary equity, shares outstanding	81,681,000	81,681,000
Shares subject to possible redemption, redemption value per share	$ 10	$ 10
Class A Ordinary Shares Subject to Redemption
Temporary equity, shares outstanding	72,816,446	70,788,131
Class B Ordinary Shares
Common shares, par value, (per share)	$ 0.00005	$ 0.00005
Common shares, shares authorized	60,000,000	60,000,000
Common shares, shares issued	20,420,250	20,420,250
Common shares, shares outstanding	20,420,250	20,420,250

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
REVENUE	$ 0	$ 0
EXPENSES
Administrative fee - related party	50,647
General and administrative	4,592,167	1,854
TOTAL EXPENSES	4,642,814	1,854
OTHER INCOME (EXPENSES)
Investment income from Trust Account	141,517
Interest expense	(615)
Change in fair value of derivative warrant liabilities	24,785,058
TOTAL OTHER INCOME (EXPENSES) - NET	24,925,960
Net income (loss)	$ 20,283,146	$ (1,854)
Class A Ordinary Shares
OTHER INCOME (EXPENSES)
Weighted average shares outstanding, basic and diluted	81,681,000
Basic and diluted net income (loss) per common share	$ 0	$ 0
Class B Ordinary Shares
OTHER INCOME (EXPENSES)
Weighted average shares outstanding, basic and diluted	20,420,250	18,750,000
Basic and diluted net income (loss) per common share	$ 0.99	$ 0

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)	Class A Ordinary Shares	Class B Ordinary Shares	Additional Paid-in Capital	Retained Earnings	Total
Balance at the beginning at Dec. 31, 2019		$ 1,021	$ 30,881	$ (30,048)	$ 1,854
Balance at the beginning (in shares) at Dec. 31, 2019		21,562,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(1,854)	(1,854)
Balance at the end at Mar. 31, 2020		$ 1,021	30,881	(31,902)
Balance at the end (in shares) at Mar. 31, 2020		21,562,500
Balance at the beginning at Dec. 31, 2020	$ 545	$ 1,021	24,670,251	(19,671,808)	5,000,009
Balance at the beginning (in shares) at Dec. 31, 2020	10,892,869	20,420,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in Class A ordinary shares subject to possible redemption	$ (102)		(20,283,048)	0	(20,283,150)
Change in Class A ordinary shares subject to possible redemption (in shares)	(2,028,315)
Net income (loss)				20,283,146	20,283,146
Balance at the end at Mar. 31, 2021	$ 443	$ 1,021	$ 4,387,203	$ 611,338	$ 5,000,005
Balance at the end (in shares) at Mar. 31, 2021	8,864,554	20,420,250

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows from Operating Activities:
Net income (loss)	$ 20,283,146	$ (1,854)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Investment income earned on investment held in Trust Account	(141,517)
Change in fair value of derivative warrant liabilities	(24,785,058)
Changes in operating assets and liabilities:
Prepaid expenses	150,174	(1,854)
Accounts payable and accrued expenses	4,138,691
Net Cash Used In Operating Activities	(354,564)
Cash Flows From Financing Activities:
Proceeds from Sponsor note	800,000
Repayment of advances from Sponsor	(371,767)
Net Cash Provided By Financing Activities	428,233
Net change in cash	73,669
Cash at beginning of period	257,872	0
Cash at end of period	331,541	$ 0
Supplemental disclosure of non-cash financing activities:
Change in value of Class A ordinary shares subject to possible redemption	$ 20,283,150

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN	3 Months Ended
	Mar. 31, 2021
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN	NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Organizational and General Apollo Strategic Growth Capital (formerly known as APH III (Sub I), Ltd.) (the “ Company we us our Initial Business Combination Securities Act JOBS Act At March 31, 2021, the Company had not commenced any operations. All activity for the period from October 10, 2008 through March 31, 2021 relates to the Company’s formation and the initial public offering (the “ Public Offering IPO st Sponsor and Public Offering On October 6, 2020, the Company consummated the Public Offering of 75,000,000 Units, $0.00005 par value at a price of $10 per unit (the “ Units Sponsor Private Placement Warrants Trust Account On November 10, 2020, the Company consummated the closing of the sale of 6,681,000 additional Units at a price of $10 per unit upon receiving notice of the underwriters’ election to partially exercise their overallotment option (“ Overallotment Units The Company intends to finance its Initial Business Combination with proceeds from the Public Offering, the Private Placement, debt or a combination of the foregoing. Trust Account The proceeds held in the Trust Account are invested only in U.S. government securities with a maturity of one hundred eighty (180) days or less or in money market funds that meet certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that invest only in direct U.S. government treasury obligations, as determined by the Company. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Initial Business Combination or (ii) the distribution of the Trust Account proceeds as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisitions and continuing general and administrative expenses. At March 31, 2021, the proceeds of the Public Offering of $817,127,050 were held in U.S. government securities, as specified above. The Company’s amended and restated memorandum and articles of association provides that, other than the withdrawal of interest to pay its tax obligations (the “ Permitted Withdrawals Public Shares Completion Window Initial Business Combination The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating an Initial Business Combination. The Initial Business Combination must occur with one or more target businesses that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting discounts and commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into the Initial Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect an Initial Business Combination. The Company, after signing a definitive agreement for an Initial Business Combination, will either (i) seek shareholder approval of the Initial Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their Public Shares, regardless of whether they vote for or against the Initial Business Combination, for cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals or (ii) provide shareholders with the opportunity to sell their Public Shares to the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to the Company to make Permitted Withdrawals. The decision as to whether the Company will seek shareholder approval of the Initial Business Combination or will allow shareholders to sell their Public Shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval, unless a vote is required by law or under New York Stock Exchange (“ NYSE If the Company holds a shareholder vote or there is a tender offer for shares in connection with an Initial Business Combination, a shareholder will have the right to redeem his, her or its Public Shares for an amount in cash equal to his, her or its pro rata share of the aggregate amount on deposit in the Trust Account as of two business days prior to the consummation of the Initial Business Combination, including interest not previously released to make Permitted Withdrawals. As a result, such Public Shares are recorded at redemption amount and classified as temporary equity upon the completion of the Public Offering, in accordance with the Accounting Standards Codification (“ ASC Distinguishing Liabilities from Equity Pursuant to the Company’s amended and restated memorandum and articles of association, if the Company is unable to complete the Initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to make Permitted Withdrawals (less up to $100,000 of such net interest to pay dissolution expenses and net of taxes payable), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and the Company’s officers and directors have entered into a letter agreement with the Company, pursuant to which they have agreed to waive their rights to liquidating distributions from the Trust Account with respect to any Founder Shares (as defined below) held by them if the Company fails to complete the Initial Business Combination within the Completion Window. However, if the Sponsor or any of the Company’s directors, officers or affiliates acquire Class A ordinary shares in or after the Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete the Initial Business Combination within the prescribed time period. In the event of a liquidation, dissolution or winding up of the Company after an Initial Business Combination, the Company’s shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of ordinary share, if any, having preference over the ordinary shares. The Company’s shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares, except that the Company will provide its shareholders with the opportunity to redeem their Public Shares for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, upon the completion of the Initial Business Combination, subject to the limitations described herein. Going Concern Considerations, Liquidity and Capital Resources As of March 31, 2021, we had investments held in the Trust Account of $817,127,050 principally invested in U.S. government securities. Interest income on the balance in the Trust Account may be used by us to pay taxes, and to pay up to $100,000 of any dissolution expenses. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Codification (“ ASC “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” The Company intends to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding the deferred underwriting commissions, to complete its Initial Business Combination. To the extent that capital stock or debt is used, in whole or in part, as consideration to complete the Initial Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue growth strategies. If an Initial Business Combination agreement requires the Company to use a portion of the cash in the Trust Account to pay the purchase price or requires the Company to have a minimum amount of cash at closing, the Company will need to reserve a portion of the cash in the Trust Account to meet such requirements or arrange for third-party financing. The Company is required to complete an Initial Business Combination within the Completion Window. If the Company is unable to complete an Initial Business Combination within the Completion Window, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, and subject to having lawfully available funds therefore, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account deposits (which interest shall be net of taxes payable and less up to $100,000 to pay dissolution expenses), divided by the number of then-outstanding public shares, which redemption will completely extinguish the public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The underwriters have agreed to waive their rights to their deferred underwriting commissions held in the trust account in the event the Company does not complete an Initial Business Combination within the Completion Window and, in such event, such amounts will be included with the funds held in the trust account that will be available to fund the redemption of the public shares. Recent Developments On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the Securities and Exchange Commission (the “ SEC Staff Statement As a result, the Company evaluated the accounting treatment for its outstanding Private Placement Warrants and Public Warrants (collectively, the “ Warrants

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation Certain information and note disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“ US GAAP Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “ Exchange Act Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Offering Costs Associated with the Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “ Expenses of Offering.” Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity. Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. There were no unrecognized tax benefits as of March 31, 2021 and December 31, 2020. Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. Net Income (Loss) per ordinary share Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. At March 31, 2021 and December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic income (loss) per share for the period presented. The Company’s statements of operations include a presentation of net income (loss) per share for ordinary shares subject to redemption in a manner similar to the two-class method. Net income (loss) per ordinary share, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the period. Net income (loss) per ordinary share, basic and diluted for Class B ordinary shares is calculated by dividing the net income (loss), less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “ Derivatives and Hedging. Fair Value Measurement,” Warrant Instruments The Company accounts for the Warrants issued in connection with the Public Offering and Private Placement in accordance with the guidance contained in ASC 815 “ Derivatives and Hedging Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Recent Accounting Standards In August 2020, the Financial Accounting Standard Board (“ FASB ASU Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity ASU 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	3 Months Ended
	Mar. 31, 2021
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3 — INITIAL PUBLIC OFFERING Pursuant to the Public Offering, the Company sold 81,681,000 Units at a purchase price of $10.00 per Unit, including the issuance of 6,681,000 Units as a results of the underwriters’ exercise of their over-allotment option, generating gross proceeds to the Company in the amount of $816,810,000. Each Unit consists of one share of the Company’s Class A ordinary shares, par value $0.00005 per share (the “ Class A ordinary shares one Public Warrant

PRIVATE PLACEMENT

PRIVATE PLACEMENT	3 Months Ended
	Mar. 31, 2021
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4 — PRIVATE PLACEMENT Pursuant to the Public Offering, the Company sold an aggregate of 12,224,134 Private Placement Warrants to the Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company in the amount of $18,336,200. A portion of the proceeds from the Private Placement Warrants was added to the proceeds from the Public Offering held in the Trust Account. If the Company does not complete an Initial Business Combination within the Completion Window, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the Initial Business Combination.

RELATED PARTIES

RELATED PARTIES	3 Months Ended
	Mar. 31, 2021
RELATED PARTIES
RELATED PARTIES	NOTE 5 — RELATED PARTIES Founder Shares In October 2008, the Company was formed by Apollo Principal Holdings III, L.P. (“ Holdings Founder Shares The Founder Shares are identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares are Class B ordinary shares which automatically convert into Class A ordinary shares at the time of the Company’s Initial Business Combination and are subject to certain transfer restrictions, as described in more detail below. The holders of the Founder Shares agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the Initial Business Combination or (B) subsequent to the Initial Business Combination, (x) if the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Related Party Loans On August 11, 2020, the Sponsor agreed to loan the Company an aggregate of up to $750,000 to cover expenses related to the Public Offering pursuant to an unsecured promissory note (the “ Note On October 20, 2020, the Sponsor executed an unsecured promissory note (the “ October Note On February 22, 2021, the Sponsor executed an unsecured promissory note (the “ February Note Advances from Related Parties Affiliates of the Sponsor paid certain formation, operating and offering costs on behalf of the Company. These advances are due on demand and are non-interest bearing. For the period from October 10, 2008 (inception) through December 31, 2020, the related parties paid $373,517 of offering costs and other expenses on behalf of the Company. As of March 31, 2021 and December 31, 2020, there was $4,222 and $373,517 due to the related parties, respectively. Administrative Service Fee Commencing on the date the Units were first listed on the NYSE, the Company has agreed to pay the Sponsor a total of $16,667 per month for office space, utilities and secretarial and administrative support for up to 27 months. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company incurred $50,646 and $46,669 for such expenses under the administrative services agreement for the three months ended March 31, 2021 and the year ended December 31, 2020, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2021
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6 — COMMITMENTS AND CONTINGENCIES Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Registration Rights The holders of the Founder Shares, Private Placement Warrants and Private Placement Warrants that may be issued upon conversion of working capital loans, if any, (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and Private Placement Warrants that may be issued upon conversion of working capital loans) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to demand that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an Initial Business Combination. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 30-day option from the date of the final prospectus to purchase up to 9,000,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions. On November 10, 2020, the Company consummated the sale of additional units pursuant to the underwriters’ partial exercise of their over-allotment option. Upon the closing of the Public Offering and the over-allotment, the underwriters were entitled to an underwriting discount of $0.20 per unit, or $16,336,200, after the underwriters’ exercised their over-allotment option, which was paid in the aggregate upon the closing of the Public Offering and the over-allotment. In addition, the underwriters are entitled to an underwriting discount of $0.35 per unit, or $28,588,350 in the aggregate is payable to the underwriters for deferred underwriting commissions. The deferred fee becomes payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an Initial Business Combination, subject to the terms of the underwriting agreement for the offering.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	3 Months Ended
	Mar. 31, 2021
SHAREHOLDERS' EQUITY
SHAREHOLDERS' EQUITY	NOTE 7 — SHAREHOLDERS’ EQUITY Preferred Shares The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.00005 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2021 and December 31, 2020, there were no preferred shares issued or outstanding. Ordinary Shares The authorized ordinary shares of the Company include up to 300,000,000 shares of Class A ordinary shares and 60,000,000 shares of Class B ordinary shares. If the Company enters into an Initial Business Combination, it may (depending on the terms of such an Initial Business Combination) be required to increase the number of Class A ordinary shares which the Company is authorized to issue at the same time as the Company’s shareholders vote on the Initial Business Combination to the extent the Company seeks shareholder approval in connection with the Initial Business Combination. Holders of the Company’s ordinary shares are entitled to one vote for each ordinary share. As of March 31, 2021 and December 31, 2020, there were 81,681,000 Class A ordinary shares, including 72,816,446 and 70,788,131 Class A ordinary shares subject to possible conversion that were classified as temporary equity in the accompanying condensed balance sheets. The Class B ordinary shares will automatically convert into our Class A ordinary shares at the time of completion of our Initial Business Combination on a one-for-one basis, subject to adjustment for share splits, share dividends, reorganizations, recapitalizations and the like and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the Initial Business Combination, the ratio at which Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the business combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the business combination). As of March 31, 2021 and December 31, 2020, there were 20,420,250 Class B ordinary shares issued and outstanding. All shares and associated amounts have been retroactively restated to reflect: (i) the forfeiture of 1,142,250 Class B ordinary shares in November 2020; and (ii) the surrender of 7,187,500 Class B ordinary shares in September 2020.

WARRANTS

WARRANTS	3 Months Ended
	Mar. 31, 2021
WARRANTS
WARRANTS	NOTE 8 — WARRANTS As of March 31, 2021 and December 31, 2021, there were 39,451,134 warrants outstanding (12,224,134 Private Placement Warrants and 27,227,000 Public Warrants). Public Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Public Warrants. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of an Initial Business Combination or (b) 12 months from the closing of the Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available (or the Company permits holders to exercise their Public Warrants on a cashless basis and such cashless exercise is exempt from registration under the Securities Act). The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of an Initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the Public Warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the Public Warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if the Company’s ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under the Securities Act, the Company, at its option, may require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement. The Public Warrants will expire five years after the completion of an Initial Business Combination or earlier upon the Company’s redemption or liquidation. The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants and the ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be non-redeemable so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. The Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported closing price of the Company’s ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. If, and only if, there is a current registration statement in effect with respect to the ordinary shares underlying such warrants at the time of redemption and a current prospectus relating to those ordinary shares is available throughout the 30-day trading period referred to above. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as will be described in the warrant agreement. The exercise price and number of the ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a share dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of ordinary shares at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete an Initial Business Combination within the Completion Window and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. The Company accounts for the 39,451,134 warrants issued in connection with the Public Offering (including 27,227,000 Public Warrants and 12,224,134 Private Placement Warrants) in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. The accounting treatment of derivative financial instruments requires that the Company record a derivative liability upon the closing of the Public Offering. Accordingly, the Company classifies each warrant as a liability at its fair value and the warrants will be allocated a portion of the proceeds from the issuance of the Units equal to its fair value determined by the Monte Carlo simulation up until separation for the Public Warrants (subsequent to separation, the public warrants will be valued using publicly available trading price) and a modified Black-Scholes model for the Private Placement Warrants. This liability is subject to re-measurement at each balance sheet date. With each such re-measurement, the warrant liability will be adjusted to fair value, with the change in fair value recognized in the Company’s statements of operations. The Company will reassess the classification at each balance sheet date. If the classification changes as a result of events during the period, the warrants will be reclassified as of the date of the event that causes the reclassification.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended
	Mar. 31, 2021
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 9 — FAIR VALUE MEASUREMENTS The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. The following table presents information about the Company’s assets and liabilities that are measured at fair value at March 31, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within liabilities on the balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the statement of operations. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Description Level March 31, 2021 December 31, 2020 Assets: ​ ​ ​ ​ Marketable securities held in Trust Account 1 ​ $ 817,127,050 ​ $ 816,985,533 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Warrant Liability – Private Placement Warrants ​ 3 ​ ​ 15,551,232 ​ ​ 23,455,550 Warrant Liability – Public Warrants 1 ​ ​ 34,306,020 ​ ​ 51,186,760 ​ Upon consummation of the Public Offering, the Company used a Monte Carlo simulation model to value the Public Warrants and a modified Black-Scholes model to value the Private Placement Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A ordinary shares and one-third of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of Class B ordinary shares, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to Class A ordinary shares subject to possible redemption (temporary equity), Class A ordinary shares (permanent equity) and Class B ordinary shares (permanent equity) based on their relative fair values at the initial measurement date. At the initial measurement date, the Warrants were classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs. As of both December 31, 2020 and March 31, 2021 the Public Warrants were valued using the publicly available price for the Warrant and are classified as Level 1 on the Fair Value Hierarchy. At March 31, 2021 and December 31, 2020, the Company used a modified Black-Scholes model to value the Private Placement Warrants. The Company relied upon the implied volatility of the Public Warrants and the closing stock price at December 31, 2020 to estimate the volatility for the Private Placement Warrants. At March 31, 2021 and December 31, 2020, the Private Placement Warrants were classified within Level 3 of the Fair Value Hierarchy at the measurement dates due to the use of unobservable inputs. The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2021: ​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement ​ ​ Using Level 3 ​ ​ Inputs ​ ​ Total Balance, December 31, 2020 ​ $ 23,455,550 Change in fair value of derivative liabilities ​ (7,904,318) Balance, March 31, 2021 ​ $ 15,551,232 ​ During the three months ended March 31, 2021, the fair value of the derivative feature of the Private Warrants was calculated using the following weighted average assumptions: ​ ​ ​ ​ ​ Risk-free interest rate 0.66 – 1.14 % Expected life of grants 5.0 years ​ Expected volatility of underlying shares 10.0 - 30.0 % Dividends 0 % ​ As of March 31, 2021 and December 31, 2020, the derivative warrant liability was $49,857,252 and $74,642,310, respectively. In addition, for the three months ended March 31, 2021, the Company recorded $24,785,058 as a gain on the change in fair value of the derivative warrant liabilities on the condensed statements of operations. Upon issuance of the Private Placement Warrants, the Company charge to additional paid in capital of $328,956 for the excess of proceeds received over fair value of Private Placement Warrant liabilities.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2021
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 10  —  SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any other subsequent events that would have required recognition or disclosure in the condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation Certain information and note disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“ US GAAP
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “ Exchange Act
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Offering Costs associated with a Public Offering	Offering Costs Associated with the Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A — “ Expenses of Offering.”
Class A Ordinary shares subject to possible redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity.
Income Taxes	Income Taxes ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. There were no unrecognized tax benefits as of March 31, 2021 and December 31, 2020. Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.
Net Income (Loss) per ordinary share	Net Income (Loss) per ordinary share Net income (loss) per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding during the period. At March 31, 2021 and December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic income (loss) per share for the period presented. The Company’s statements of operations include a presentation of net income (loss) per share for ordinary shares subject to redemption in a manner similar to the two-class method. Net income (loss) per ordinary share, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account by the weighted average number of Class A ordinary shares outstanding for the period. Net income (loss) per ordinary share, basic and diluted for Class B ordinary shares is calculated by dividing the net income (loss), less income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “ Derivatives and Hedging. Fair Value Measurement,”
Warrant Instruments	Warrant Instruments The Company accounts for the Warrants issued in connection with the Public Offering and Private Placement in accordance with the guidance contained in ASC 815 “ Derivatives and Hedging
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid to transfer of a liability, in an orderly transaction between market participants at the measurement date. US GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
Recent Accounting Standards	Recent Accounting Standards In August 2020, the Financial Accounting Standard Board (“ FASB ASU Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity ASU 2020-06 Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended
	Mar. 31, 2021
FAIR VALUE MEASUREMENTS
Schedule of Company's assets and liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Description Level March 31, 2021 December 31, 2020 Assets: ​ ​ ​ ​ Marketable securities held in Trust Account 1 ​ $ 817,127,050 ​ $ 816,985,533 ​ ​ ​ ​ ​ ​ ​ ​ ​ Liabilities: ​ ​ ​ ​ Warrant Liability – Private Placement Warrants ​ 3 ​ ​ 15,551,232 ​ ​ 23,455,550 Warrant Liability – Public Warrants 1 ​ ​ 34,306,020 ​ ​ 51,186,760
Schedule of the changes in fair value, including net transfers in all financial assets and liabilities	​ ​ ​ ​ ​ ​ Fair Value ​ ​ Measurement ​ ​ Using Level 3 ​ ​ Inputs ​ ​ Total Balance, December 31, 2020 ​ $ 23,455,550 Change in fair value of derivative liabilities ​ (7,904,318) Balance, March 31, 2021 ​ $ 15,551,232
Schedule of the fair value of the derivative feature of the Private warrants	​ ​ ​ ​ ​ Risk-free interest rate 0.66 – 1.14 % Expected life of grants 5.0 years ​ Expected volatility of underlying shares 10.0 - 30.0 % Dividends 0 %

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details)	Feb. 09, 2021shares	Nov. 10, 2020USD ($)$ / sharesshares	Oct. 06, 2020USD ($)$ / sharesshares	Mar. 31, 2021USD ($)Mshares	Dec. 31, 2020USD ($)
Subsidiary, Sale of Stock [Line Items]
Investments held in Trust			$ 750,000,000
Offering cost			43,541,714
Underwriting fees			15,000,000
Deferred underwriting fee payable			$ 26,250,000
Other offering costs				$ 2,344,508
Cash held outside the Trust Account				$ 331,541	$ 257,872
Condition for future business combination number of businesses minimum | M				24
Payments for investment of cash in Trust Account				$ 817,127,050
Condition for future business combination use of proceeds percentage				100
Condition for future business combination threshold Percentage Ownership				100
Condition for future business combination threshold Net Tangible Assets				$ 5,000,001
Redemption limit percentage without prior consent				80
Maximum Allowed Dissolution Expenses				$ 100,000
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares				27,227,000
Sponsor | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued | shares		890,800	11,333,334
Price of warrants (in dollars per share) | $ / shares			$ 1.50
Proceeds from sale of Private Placement Warrants		$ 1,336,200	$ 17,000,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares	81,681,000		75,000,000	39,451,134
Unit Par Value | $ / shares			$ 0.00005
Unit Price | $ / shares			$ 10
Proceeds from offering			$ 750,000,000
Investments held in Trust			$ 800,877
Proceeds from issuance initial public offering				$ 817,127,050
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued | shares				12,224,134
Proceeds from sale of Private Placement Warrants				$ 18,336,200
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued | shares		6,681,000		9,000,000
Unit Price | $ / shares		$ 10
Proceeds from offering		$ 66,810,000
Offering cost		3,674,550
Deferred underwriting fee payable		$ 2,338,350
Over-allotment option | Founder Shares
Subsidiary, Sale of Stock [Line Items]
Maximum shares subject to forfeiture | shares		1,142,250

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Other offering costs	$ 2,344,508
Public offering costs	800,877
Underwriter discount	44,924,550
Unrecognized tax benefits	$ 0	$ 0
Statutory tax rate (as a percent)	0.00%
Class A common stock subject to possible redemption	$ 728,164,460	$ 707,881,310
Initial Public Offering
Proceeds from issuance initial public offering	$ 817,127,050

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Feb. 09, 2021	Nov. 10, 2020	Oct. 06, 2020	Mar. 31, 2021	Dec. 31, 2020
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of units issued				27,227,000
Purchase price, per unit				$ 0.01
Class A Ordinary Shares
Subsidiary, Sale of Stock [Line Items]
Common Stock, Par or Stated Value Per Share				$ 0.00005	$ 0.00005
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units issued	81,681,000		75,000,000	39,451,134
Purchase price, per unit	$ 10
Proceeds from issuance initial public offering				$ 817,127,050
Number of shares in a unit	6,681,000
Initial Public Offering | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants in a unit	0.2
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Initial Public Offering | Class A Ordinary Shares
Subsidiary, Sale of Stock [Line Items]
Proceeds from issuance initial public offering	$ 816,810,000
Common Stock, Par or Stated Value Per Share	$ 0.00005
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Number of units issued		6,681,000		9,000,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - Private Placement Warrants - USD ($)	Nov. 10, 2020	Oct. 06, 2020	Mar. 31, 2021
Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued	890,800	11,333,334
Aggregate purchase price	$ 1,336,200	$ 17,000,000
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination			30 days
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued			12,224,134
Price of warrants			$ 1.50
Aggregate purchase price			$ 18,336,200

RELATED PARTIES - Founder Share

RELATED PARTIES - Founder Shares (Details)

Sep. 16, 2020shares

Sep. 30, 2020item$ / sharesshares

Oct. 31, 2008shares

Mar. 31, 2021$ / sharesshares

Feb. 28, 2021shares

Feb. 22, 2021

Dec. 31, 2020$ / sharesshares

Nov. 10, 2020shares

Oct. 06, 2020shares

Aug. 06, 2020shares

Mar. 31, 2020shares

Dec. 31, 2019shares

Related Party Transaction [Line Items]

Number of independent directors | item

3

Private Placement Warrants | Private Placement

Related Party Transaction [Line Items]

Price of warrant | $ / shares

$ 1.50

Number of warrants to purchase shares issued

12,224,134

Class B Ordinary Shares

Related Party Transaction [Line Items]

Ordinary shares outstanding

20,420,250

20,420,250

Common shares, par value (in dollars per share) | $ / shares

$ 0.00005

$ 0.00005

Surrendered founder shares

20,420,250

20,420,250

21,562,500

21,562,500

Sponsor

Related Party Transaction [Line Items]

Debt Instrument, Interest Rate, Stated Percentage

0.12%

Sponsor | Private Placement Warrants

Related Party Transaction [Line Items]

Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination

30 days

Number of warrants to purchase shares issued

890,800

11,333,334

Founder Shares

Related Party Transaction [Line Items]

Number of shares issued

1

Founder Shares

Related Party Transaction [Line Items]

Ordinary shares outstanding

21,562,500

Surrendered founder shares

7,187,500

Holding of shares

25,000

Purchase price, per unit | $ / shares

$ 0.00087

Recapitalization ratio

1.33333

Founder Shares | Over-allotment option

Related Party Transaction [Line Items]

Maximum shares subject to forfeiture

1,142,250

Founder Shares | Class B Ordinary Shares

Related Party Transaction [Line Items]

Ordinary shares outstanding

75,000

28,750,000

Purchase price, per unit | $ / shares

$ 65.25

Founder Shares | Sponsor | Class B Ordinary Shares

Related Party Transaction [Line Items]

Shares subject to forfeiture

1,142,500

Restrictions on transfer period of time after business combination completion

1 year

Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) | $ / shares

$ 12

Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination

20 days

Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination

30 days

Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences

150 days

RELATED PARTIES - Additional In

RELATED PARTIES - Additional Information (Details) - USD ($)	Dec. 28, 2020	Oct. 20, 2020	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2020	Feb. 22, 2021
Related Party Transaction [Line Items]
Outstanding balance of related party note			$ 1,500,000
Repayment of promissory note - related party			371,767
Due to Related Parties			$ 4,222	$ 373,517	$ 373,517
Threshold period for which expenses are paid			27 months
Outstanding balance			$ 800,000			$ 800,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Principle amount of promissory note						$ 800,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 1,500,000
Expenses incurred	$ 750,000
Interest rate	0.17%	0.14%
Principle amount of promissory note		$ 1,500,000
Advances From Related Parties [Member]
Related Party Transaction [Line Items]
Offering costs and other expenses					$ 373,517
Administrative Services Agreement [Member]
Related Party Transaction [Line Items]
Expenses per month			16,667
Expenses incurred			$ 50,646	$ 46,669

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details) - USD ($)	Nov. 10, 2020	Mar. 31, 2021
Loss Contingencies [Line Items]
Underwriting cash discount per unit		$ 0.20
Aggregate underwriter cash discount		$ 16,336,200
Deferred fee per unit		$ 0.35
Aggregate deferred underwriting fee payable		$ 28,588,350
Over-allotment option
Loss Contingencies [Line Items]
Number of units issued	6,681,000	9,000,000

SHAREHOLDERS' EQUITY - Preferre

SHAREHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
SHAREHOLDERS' EQUITY
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares par value	$ 0.00005
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

SHAREHOLDERS' EQUITY - Common S

SHAREHOLDERS' EQUITY - Common Stock Shares (Details)	1 Months Ended
	Nov. 30, 2020shares	Sep. 30, 2020shares	Mar. 31, 2021Voteshares	Dec. 31, 2020shares
Class of Stock [Line Items]
Converted basis of ordinary shares outstanding			20.00%
Class A Ordinary Shares
Class of Stock [Line Items]
Increased ordinary shares authorized			300,000,000
Common shares, votes per share | Vote			1
Class A common stock subject to possible redemption, outstanding (in shares)			81,681,000	81,681,000
Common shares, shares issued (in shares)			8,864,554	10,892,869
Ordinary shares outstanding			8,864,554	10,892,869
Class A Ordinary Shares Subject to Redemption
Class of Stock [Line Items]
Class A common stock subject to possible redemption, outstanding (in shares)			72,816,446	70,788,131
Class B Ordinary Shares
Class of Stock [Line Items]
Increased ordinary shares authorized			60,000,000
Common shares, shares issued (in shares)			20,420,250	20,420,250
Ordinary shares outstanding			20,420,250	20,420,250
Common stock, shares subject to forfeiture (in shares)	1,142,250
Common stock, shares subject to surrender (in shares)		7,187,500

WARRANTS (Details)

WARRANTS (Details) - USD ($)	Feb. 09, 2021	Oct. 06, 2020	Mar. 31, 2021	Dec. 31, 2020
Warrants liabilities.
Warrants outstanding			39,451,134	39,451,134
Weighted average trading days			20 days
Ordinary shares exercisable			$ 18
Public warrants expire			30 days
Warrant liabilities			$ 57,753,222
Minimum
Warrants liabilities.
Weighted average trading days			30 days
Initial Public Offering
Warrants liabilities.
Purchase price, per unit	$ 10
Units Issued During Period, Shares, New Issues	81,681,000	75,000,000	39,451,134
Public Warrants
Warrants liabilities.
Warrants outstanding			27,227,000	27,227,000
Purchase price, per unit			$ 0.01
Units Issued During Period, Shares, New Issues			27,227,000
Private Placement Warrants
Warrants liabilities.
Warrants outstanding			12,224,134	12,224,134
Private Placement
Warrants liabilities.
Units Issued During Period, Shares, New Issues			12,224,134

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Assets:
Marketable securities held in Trust Account	$ 817,127,050	$ 816,985,533
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	49,857,252	74,642,310
Level 1 | Recurring
Assets:
Marketable securities held in Trust Account	817,127,050	816,985,533
Level 1 | Recurring | Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	34,306,020	51,186,760
Level 3 | Recurring | Private Placement Warrants
Liabilities, Fair Value Disclosure [Abstract]
Derivative warrant liabilities	$ 15,551,232	$ 23,455,550

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details)	3 Months Ended
	Mar. 31, 2021USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 74,642,310
Change in fair value of derivative warrant liabilities	24,785,058
Ending Balance	49,857,252
Level 3
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	23,455,550
Change in fair value of derivative warrant liabilities	(7,904,318)
Ending Balance	$ 15,551,232

FAIR VALUE MEASUREMENTS - Level

FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)	3 Months Ended
	Mar. 31, 2021USD ($)	Dec. 31, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	$ 49,857,252	$ 74,642,310
Change in fair value of derivative warrant liabilities	24,785,058
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities	15,551,232	$ 23,455,550
Change in fair value of derivative warrant liabilities	(7,904,318)
Excess of proceeds received over fair value of private warrant liabilities charged to additional paid in capital	$ 328,956
Expected life of grants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	5
Dividends
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0
Maximum | Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	1.14
Maximum | Expected volatility of underlying shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	30
Minimum | Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.66
Minimum | Expected volatility of underlying shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	10